文献速递乳腺乳腺X线

前瞻性人群Malmö乳腺断层合成筛查试验中的间期癌发生率与肿瘤特征

Interval Breast Cancer Rates and Tumor Characteristics in the Prospective Population-based Malmö Breast Tomosynthesis Screening Trial.
PubMed 文献 · Radiology · 2021-04-06

该前瞻性人群试验比较了单视图DBT与双视图DM的乳腺癌检出,并将MBTST组与同龄同期DM筛查对照组比较间期癌发生率和肿瘤特征。

要点

  • DBT筛查可降低间期癌发生率,提示可能带来筛查获益。
  • DBT组间期癌侵袭性多较高,高Ki-67比例63%。
  • 间期癌评估是评价乳腺筛查获益的重要指标。

核心结论

  • DBT筛查相比当代同龄DM筛查对照组降低了间期癌发生率,可能转化为筛查获益。
  • 试验组间期癌一般具有非 favorable 特征(高Ki-67、低luminal A-like比例)。

研究设计与样本

  • 前瞻性人群为基础筛查试验(MBTST),设计比较单视图DBT与双视图DM的乳腺癌检出。
  • DBT组纳入14 848名女性,其中13 369名与同期DM筛查对照组26 738名按年龄和筛查场次1:2匹配。
  • 采用条件logistic回归分析间期癌率,并与年龄匹配的当代DM筛查对照组比较。

诊断标准与关键数值

  • DBT组间期癌率为1.6/1000(21/13 369,95%CI 1.0–2.4),对照组为2.8/1000(76/26 738,95%CI 2.2–3.6)。
  • 侵袭性间期癌中高Ki-67比例:DBT组63%(12/19),对照组75%(54/72)。
  • luminal A-like亚型比例:DBT组26%(5/19),对照组17%(12/72)。

临床应用与阅片要点

  • 间期癌率可作为评估DBT筛查获益的补充指标,阅片报告时可关注筛查后间期癌的发生情况。
  • DBT检出的间期癌多具高增殖特征,提示需持续优化筛查方案以检出更具侵袭性的肿瘤。
  • 对比DBT与DM筛查效果时,应结合间期癌率及肿瘤生物学特征综合判断,而非仅看检出率。

局限性

  • 研究为单中心设计,结果外推需谨慎。
  • DBT组采用单视图,与临床常用双视图DBT可能不同。
  • 原文未报告样本量以外的多中心验证数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Interval cancer rates can be used to evaluate whether screening with digital breast tomosynthesis (DBT) contributes to a screening benefit. Purpose To compare interval cancer rates and tumor characteristics in DBT screening to those in a contemporary population screened with digital mammography (DM). Materials and Methods The prospective population-based Malmö Breast Tomosynthesis Screening Trial (MBTST) was designed to compare one-view DBT to two-view DM in breast cancer detection. The interval cancer rates and cancer characteristics in the MBTST were compared with an age-matched contemporary control group, screened with two-view DM at the same center. Conditional logistic regression was used for data analysis. Results There were 14 848 women who were screened with DBT and DM in the MBTST between January 2010 and February 2015. The trial women were matched with two women of the same age and screening occasion at DM screening during the same period. Matches for 13 369 trial women (mean age, 56 years ± 10 [standard deviation]) were found with 26 738 women in the control group (mean age, 56 years ± 10). The interval cancer rate in the MBTST was 1.6 per 1000 screened women (21 of 13 369; 95% CI: 1.0, 2.4) compared with 2.8 per 1000 screened women in the control group (76 of 26 738 [95% CI: 2.2, 3.6]; conditional odds ratio, 0.6 [95% CI: 0.3, 0.9]; P = .02). The invasive interval cancers in the MBTST and in the control group showed in general high Ki-67 (63% [12 of 19] and 75% [54 of 72]), and low proportions of luminal A-like subtype (26% [five of 19] and 17% [12 of 72]), respectively. Conclusion The reduced interval cancer rate after screening with digital breast tomosynthesis compared with a contemporary age-matched control group screened with digital mammography might translate into screening benefits. Interval cancers in the trial generally had nonfavorable characteristics. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Mann in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Johnson K, Lång K, Ikeda DM, et al. Interval Breast Cancer Rates and Tumor Characteristics in the Prospective Population-based Malmö Breast Tomosynthesis Screening Trial. Radiology. 2021. PMID: 33825509. doi:10.1148/radiol.2021204106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。